TOP 1630Alternative Names: TOP1630
Latest Information Update: 29 Nov 2016
At a glance
- Originator TopiVert
- Mechanism of Action P38 mitogen-activated protein kinase inhibitors; Protein kinase inhibitors; Src-Family kinase inhibitors; Syk kinase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes - Dry eyes
Highest Development Phases
- Preclinical Dry eyes